AG Mednet continues its drive to advance clinical trials with the launch of Judi, a comprehensive electronic endpoint adjudication system to manage workflow and ensure data quality. Judi helps sponsors and CROs manage clinical events from trigger to final adjudication in pharmaceutical, biologic and medical device clinical trials. This product capitalizes on AG Mednet’s experience delivering software in support of zero-delay clinical trials. AG Mednet is a specialized, electronic data collection and submission service dedicated to increasing data quality and reducing queries in clinical trials.
“We built Judi to improve the endpoint adjudication process,” said Abraham Gutman, AG Mednet president and CEO. “This critical process in advancing clinical trials has long suffered from lack of automation and data quality challenges. Using Judi allows for cleaner project management, reduced queries and more expediency during endpoint adjudication, all while improving quality.”
Judi, an integrated SaaS tool, provides a level of flexibility that enables the implementation of the most complex endpoint and adverse event processes, translating into more easily managed projects, fewer queries, higher accountability and increased quality throughout. Judi serves four distinct stakeholders across the endpoint adjudication spectrum:
From improved and automated workflows, to eCRF integration, electronic voting, dossier management and robust reporting, Judi eliminates the need for face-to-face meetings and streamlines the entire adjudication process. The introduction of Judi also adds these key features:
CDISC Control and Ad Hoc Dictionary Per Form Element: Judi has an internal, configurable dictionary so different representations can exist concurrently.